NEOPLASM, HP:0002664

This is a cluster of phenotypes following the categories of HPO


It has 349 associated diseases.

Show diseases

Associated diseases: WILMS TUMOR, SOMATIC, WILMS TUMOR, WILMS TUMOR, TYPE 1, POLYPOSIS, JUVENILE INTESTINAL, JUVENILE POLYPOSIS SYNDROME, INFANTILE FORM, ?NEUTROPHILIA, HEREDITARY, PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, PORPHYRIA, ACUTE INTERMITTENT, MULTIPLE ENDOCRINE NEOPLASIA IIB, GASTRIC CANCER, SOMATIC, DESMOID DISEASE, HEREDITARY, COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6, DYSKERATOSIS CONGENITA, X-LINKED, NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA, NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS, EXOSTOSES, MULTIPLE, TYPE 1, RUIJS-AALFS SYNDROME, LEUKEMIA, ACUTE PROMYELOCYTIC, SOMATIC, LEUKEMIA, ACUTE PROMYELOCYTIC, NEUROFIBROMATOSIS, FAMILIAL SPINAL, ADAMS-OLIVER SYNDROME 5, CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2, BOHRING-OPITZ SYNDROME, ?CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE, B, BECKWITH-WIEDEMANN SYNDROME, PITUITARY ADENOMA, PROLACTIN-SECRETING, ICHTHYOSIS, X-LINKED, EWING SARCOMA, NEUROEPITHELIOMA, LYMPHOMA, MALT, SOMATIC, GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS, ?MARDEN-WALKER SYNDROME, PEUTZ-JEGHERS SYNDROME, ROTHMUND-THOMSON SYNDROME, FAMILIAL COLORECTAL CANCER, MELNICK-FRASER SYNDROME, KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, BURKITT LYMPHOMA, MEDULLOBLASTOMA, DESMOPLASTIC, {MEDULLOBLASTOMA}, MEDULLOBLASTOMA, COWDEN SYNDROME 6, HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC, RESISTANT TO IMATINIB, FRONTONASAL DYSPLASIA 1, NASOPHARYNGEAL CARCINOMA, NEUROFIBROMATOSIS, TYPE 1, {MESOTHELIOMA, SOMATIC}, MESOTHELIOMA, SOMATIC, MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1, EMBERGER SYNDROME, PENDRED SYNDROME, KAHRIZI SYNDROME, SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY, SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME, PACHYONYCHIA CONGENITA 4, FANCONI ANEMIA, COMPLEMENTATION GROUP D1, GLYCOGEN STORAGE DISEASE IA, SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1, PITUITARY ADENOMA, GROWTH HORMONE-SECRETING 2, SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME, SOMATIC MOSAIC, HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE, GERM CELL TUMORS,; TESTICULAR TUMOR, SOMATIC,; SPERMATOCYTIC SEMINOMA, SOMATIC, HYPOCALCIURIC HYPERCALCEMIA, TYPE II, ADENOMAS, SALIVARY GLAND PLEOMORPHIC, SOMATIC, CLOVE SYNDROME, SOMATIC, FAMILIAL ADENOMATOUS POLYPOSIS 3, {COLORECTAL CANCER, SUSCEPTIBILITY TO, 3}, BREAST-OVARIAN CANCER, FAMILIAL 1, ?CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL, GLYCOGEN STORAGE DISEASE IC, HEMOCHROMATOSIS TYPE 1, CRANIOLENTICULOSUTURAL DYSPLASIA, TUBEROUS SCLEROSIS-1, FANCONI ANEMIA, COMPLEMENTATION GROUP G, LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1, TYROSINEMIA, TYPE I, PULMONARY FIBROSIS, IDIOPATHIC, {PULMONARY FIBROSIS, IDIOPATHIC, SUSCEPTIBILITY TO}, COWDEN SYNDROME 3, WERNER SYNDROME, GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2, XERODERMA PIGMENTOSUM, VARIANT TYPE, PLEUROPULMONARY BLASTOMA, METACHONDROMATOSIS, FANCONI ANEMIA, COMPLEMENTATION GROUP D2, DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA, ?FIBROMATOSIS, GINGIVAL, 1, CARNEY COMPLEX, TYPE 1, OSTEOSARCOMA, SOMATIC, OSTEOSARCOMA, LEUKEMIA, CHRONIC MYELOID, SOMATIC, CARTILAGE-HAIR HYPOPLASIA, OROFACIODIGITAL SYNDROME VI, CAUDAL REGRESSION SYNDROME, CURRARINO SYNDROME, XERODERMA PIGMENTOSUM, GROUP B, COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4, FANCONI ANEMIA, COMPLEMENTATION GROUP C, PROTEUS SYNDROME, SOMATIC, PROSTATE CANCER 1, {SCHWANNOMATOSIS-2, SUSCEPTIBILITY TO}, MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME, {WILMS TUMOR SUSCEPTIBILITY-5}, FANCONI ANEMIA, COMPLEMENTATION GROUP A, FANCONI ANEMIA, COMPLEMENTATION GROUP P, SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADA DEFICIENCY, ADENOSINE DEAMINASE DEFICIENCY, PARTIAL, ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME, SOMATIC, BONE MARROW FAILURE SYNDROME 1, HISTIOCYTOMA, ANGIOMATOID FIBROUS, SOMATIC, CHIME SYNDROME, PARAGANGLIOMAS 5, {?THYROID CANCER, NONMEDULLARY, 5}, NIJMEGEN BREAKAGE SYNDROME, SILVER-RUSSELL SYNDROME, NEUROFIBROMATOSIS-NOONAN SYNDROME, {MELANOMA, CUTANEOUS MALIGNANT, 9}, LEOPARD SYNDROME 3, NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT, MUCOLIPIDOSIS II ALPHA/BETA, CARCINOID TUMORS, INTESTINAL, {PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO}, PHEOCHROMOCYTOMA, {PHEOCHROMOCYTOMA, MODIFIER OF}, ADENOMAS, MULTIPLE COLORECTAL, {GASTRIC CANCER RISK AFTER H. PYLORI INFECTION}, GASTRIC CANCER, FAMILIAL DIFFUSE, WITH OR WITHOUT CLEFT LIP AND/OR PALATE, GASTRIC CANCER, SOMATIC, ACUTE MYELOID LEUKEMIA, M6 TYPE, OROFACIODIGITAL SYNDROME IV, ATAXIA-TELANGIECTASIA, {BREAST-OVARIAN CANCER, FAMILIAL, 2}, OMODYSPLASIA 1, OLIGODONTIA-COLORECTAL CANCER SYNDROME, CHONDROSARCOMA, EXTRASKELETAL MYXOID, BROOKE-SPIEGLER SYNDROME, MULIBREY NANISM, SOTOS SYNDROME 1, PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA, OCCIPITAL HORN SYNDROME, PARATHYROID CARCINOMA, DENYS-DRASH SYNDROME, CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, CENTRAL HYPOVENTILATION SYNDROME, CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, WITH OR WITHOUT HIRSCHSPRUNG DISEASE, HADDAD SYNDROME, CYLINDROMATOSIS, FAMILIAL, RENAL CELL CARCINOMA, PAPILLARY, 1, EPIDERMAL NEVUS, DIASTROPHIC DYSPLASIA, DIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, ESOPHAGEAL CARCINOMA, SOMATIC ESOPHAGEAL CARCINOMA, SOMATIC, ESOPHAGEAL CANCER, SOMATIC, ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC, ESOPHAGEAL CANCER, ESOPHAGEAL SQUAMOUS CELL CARCINOMA, LEGIUS SYNDROME, GAUCHER DISEASE, TYPE I, EPIDERMOLYSIS BULLOSA DYSTROPHICA, AR, EBD INVERSA, {EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, MODIFIER OF}, SHWACHMAN-DIAMOND SYNDROME, {MELANOMA, CUTANEOUS MALIGNANT, 3}, {MELANOMA, CUTANEOUS MALIGNANT, 2}, LEIOMYOMATOSIS AND RENAL CELL CANCER, ADRENAL CORTICAL CARCINOMA, LYMPHANGIOLEIOMYOMATOSIS, LYMPHANGIOLEIOMYOMATOSIS, SOMATIC, BREAST CANCER, SOMATIC, BREAST CANCER, EARLY-ONSET, {BREAST CANCER, PROTECTION AGAINST}, {BREAST CANCER, INVASIVE DUCTAL}, {BREAST CANCER, MALE, SUSCEPTIBILITY TO}, BREAST CANCER, {BREAST CANCER}, {BREAST CANCER, LOBULAR}, {?BREAST CANCER SUSCEPTIBILITY}, {BREAST CANCER, SUSCEPTIBILITY TO}, ?SARCOMA, SYNOVIAL, BASAL CELL CARCINOMA, SOMATIC, ALAGILLE SYNDROME, ?CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY, CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION, LI-FRAUMENI SYNDROME 2, NEUTROPENIA, SEVERE CONGENITAL 3, AUTOSOMAL RECESSIVE, SAETHRE-CHOTZEN SYNDROME, SAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, JUVENILE MYELOMONOCYTIC LEUKEMIA NOONAN SYNDROME 1, MACROGLOBULINEMIA, WALDENSTROM, SOMATIC, ?N SYNDROME, {DEBRISOQUINE SENSITIVITY}, {CODEINE SENSITIVITY}, BLOOM SYNDROME, HYALINE FIBROMATOSIS SYNDROME, POROKERATOSIS 1, MULTIPLE TYPES, ERYTHROCYTOSIS, FAMILIAL, 2, ESCOBAR SYNDROME, PIEBALDISM, MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV, BRANCHIOOCULOFACIAL SYNDROME, PAPILLARY THYROID CARCINOMA, OPTIC NERVE HYPOPLASIA AND ABNORMALITIES OF THE CENTRAL NERVOUS SYSTEM, MICROPHTHALMIA, SYNDROMIC 3, ENDOMETRIAL CANCER, FAMILIAL, {ENDOMETRIAL CANCER, SUSCEPTIBILITY TO}, ENDOMETRIAL CARCINOMA, SOMATIC, {MULTIPLE MYELOMA, SUSCEPTIBILITY TO}, {MULTIPLE MYELOMA, RESISTANCE TO}, SYMMETRIC CIRCUMFERENTIAL SKIN CREASES, CONGENITAL, 1, TUMOR PREDISPOSITION SYNDROME, {COLORECTAL CANCER, SUSCEPTIBILITY TO, 12}, ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS, NEUROCUTANEOUS MELANOSIS, SOMATIC, PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY, PAGET DISEASE OF BONE 3, {PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY, SOMATIC}, DIAMOND-BLACKFAN ANEMIA 1, [AXILLARY ODOR, VARIATION IN], [EARWAX, WET/DRY], [COLOSTRUM SECRETION, VARIATION IN], PULMONARY VENOOCCLUSIVE DISEASE 2, BASAL CELL NEVUS SYNDROME, {PULMONARY FIBROSIS, IDIOPATHIC, SUSCEPTIBILITY TO}, {APLASTIC ANEMIA}, XERODERMA PIGMENTOSUM, TYPE F/COCKAYNE SYNDROME, XERODERMA PIGMENTOSUM, GROUP F, THROMBOCYTHEMIA 1, THROMBOCYTHEMIA, SOMATIC, LYMPHEDEMA, HEREDITARY, IA, ACROMEGALY, SOMATIC, PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, TROPICAL CALCIFIC PANCREATITIS, {FIBROCALCULOUS PANCREATIC DIABETES, SUSCEPTIBILITY TO}, ZIMMERMANN-LABAND SYNDROME 1, WILMS TUMOR 2, PHEOCHROMOCYTOMA GASTROINTESTINAL STROMAL TUMOR PARAGANGLIOMAS 3, CUTANEOUS MALIGNANT MELANOMA 8, FANCONI ANEMIA, COMPLEMENTATION GROUP E, SC PHOCOMELIA SYNDROME, COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5, SCHWANNOMATOSIS, {SCHWANNOMATOSIS-1, SUSCEPTIBILITY TO}, PANCREATIC CANCER, SOMATIC, PANCREATIC CANCER, SOMATIC PANCREATIC CANCER, PANCREATIC CARCINOMA, SOMATIC, NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN,; {NONSMALL CELL LUNG CANCER, SUSCEPTIBILITY TO},; ADENOCARCINOMA OF LUNG, RESPONSE TO TYROSINE KINASE INHIBITOR IN,; {LUNG CANCER, PROTECTION AGAINST},; {LUNG CANCER, SUSCEPTIBILITY TO},; LUNG CANCER, SOMATIC,; NONSMALL CELL LUNG CANCER, SOMATIC,; LUNG CANCER,; {LUNG CANCER, RESISTANCE TO},; ADENOCARCINOMA OF LUNG, SOMATIC, RENAL CELL CARCINOMA, PAPILLARY, RENAL CELL CARCINOMA, PAPILLARY, 1, FAMILIAL AND SOMATIC, IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY, JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME, GINGIVAL FIBROMATOSIS WITH HYPERTRICHOSIS, MYELOFIBROSIS, SOMATIC, MYELOFIBROSIS WITH MYELOID METAPLASIA, SOMATIC, TERMINAL OSSEOUS DYSPLASIA, PORPHYRIA CUTANEA TARDA, PORPHYRIA, HEPATOERYTHROPOIETIC, {PORPHYRIA CUTANEA TARDA, SUSCEPTIBILITY TO}, COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7, LEUKEMIA, JUVENILE MYELOMONOCYTIC, LEUKEMIA, ACUTE MYELOMONOCYTIC, SOMATIC, LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC, RHABDOMYOSARCOMA, SOMATIC, {PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1}, COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2, MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC, {GLIOBLASTOMA 3}, RHABDOMYOSARCOMA, EMBRYONAL, 2, EMPHYSEMA DUE TO AAT DEFICIENCY, HEMORRHAGIC DIATHESIS DUE TO \'ANTITHROMBIN\' PITTSBURGH, EMPHYSEMA-CIRRHOSIS, DUE TO AAT DEFICIENCY, OSSEOUS HETEROPLASIA, PROGRESSIVE, RENAL CELL CARCINOMA, RENAL CELL CARCINOMA, SOMATIC, RENAL CARCINOMA, CHROMOPHOBE, SOMATIC, RENAL CELL CARCINOMA, CLEAR CELL, SOMATIC, {RENAL CELL CARCINOMA}, ROBERTS SYNDROME, DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3, MULTIPLE ENDOCRINE NEOPLASIA IIA, XERODERMA PIGMENTOSUM, GROUP C, BANNAYAN-RILEY-RUVALCABA SYNDROME, BALLER-GEROLD SYNDROME, LEUKEMIA, ACUTE LYMPHOBLASTIC, LEUKEMIA, ACUTE LYMPHOBLASTIC, SOMATIC, LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SOMATIC, T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, SOMATIC, LEUKEMIA, T-CELL ACUTE LYMPHOCYTIC, SOMATIC, LEUKEMIA, ACUTE LYMPHOCYTIC, SOMATIC, LEUKEMIA, MEGAKARYOBLASTIC, WITH OR WITHOUT DOWN SYNDROME, SOMATIC, SMALL CELL CANCER OF THE LUNG, SOMATIC, IMMUNODEFICIENCY DUE TO PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY, COWDEN SYNDROME 1, LHERMITTE-DUCLOS SYNDROME, {NEUROBLASTOMA, SUSCEPTIBILITY TO, 2}, NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE, MEDULLARY THYROID CARCINOMA, FAMILIAL, MEDULLARY THYROID CARCINOMA, MACROCYTIC ANEMIA, REFRACTORY, DUE TO 5Q DELETION, SOMATIC, CERVICAL CANCER, SOMATIC, IMMUNODEFICIENCY, COMMON VARIABLE, 2, {SPINA BIFIDA, SUSCEPTIBILITY TO}, NEURAL TUBE DEFECTS, {NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO}, TYLOSIS WITH ESOPHAGEAL CANCER, ALPORT SYNDROME, COWDEN SYNDROME 4, STURGE-WEBER SYNDROME, SOMATIC, MOSAIC, MYELOID LEUKEMIA, ACUTE, M4/M4EO SUBTYPE, SOMATIC,; LEUKEMIA, ACUTE MYELOID, REDUCED SURVIVAL IN, SOMATIC,; {LEUKEMIA, ACUTE MYELOID},; LEUKEMIA, ACUTE MYELOID, SOMATIC,; {LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO},; LEUKEMIA, ACUTE MYELOID,; ?LEUKEMIA, ACUTE MYELOID, {PANCREATIC CANCER 2}, MYELOPROLIFERATIVE DISORDER WITH EOSINOPHILIA, FRASIER SYNDROME, COSTELLO SYNDROME, CONGENITAL MYOPATHY WITH EXCESS OF MUSCLE SPINDLES, 46XY SEX REVERSAL 6, SQUAMOUS CELL CARCINOMA, HEAD AND NECK,; SQUAMOUS CELL CARCINOMA, HEAD AND NECK, SOMATIC, PARATHYROID ADENOMA WITH CYSTIC CHANGES, HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, {VON HIPPEL-LINDAU SYNDROME, MODIFIER OF}, VON HIPPEL-LINDAU SYNDROME, MUIR-TORRE SYNDROME, COWDEN SYNDROME 5, WATSON SYNDROME, NEPHROTIC SYNDROME, TYPE 4, OROFACIODIGITAL SYNDROME I, STEATOCYSTOMA MULTIPLEX, BLADDER CANCER, SOMATIC, {BLADDER CANCER, SOMATIC}, PILOMATRICOMA, SOMATIC, COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE, WITH PILOMATRICOMAS, PALLISTER-HALL SYNDROME, EPIDERMODYSPLASIA VERRUCIFORMIS, PARAGANGLIOMAS 4, ADENOMATOUS POLYPOSIS COLI, GARDNER SYNDROME, BRAIN TUMOR-POLYPOSIS SYNDROME 2, EXOSTOSES, MULTIPLE, TYPE 2, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA, TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE, HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III, RHABDOMYOSARCOMA 2, ALVEOLAR, RHABDOMYOSARCOMA, ALVEOLAR, {CELIAC DISEASE, SUSCEPTIBILITY TO}, COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8, OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME, PARAGANGLIOMAS 3, {RHABDOID PREDISPOSITION SYNDROME 1}, RHABDOID TUMORS, SOMATIC, HEPATIC ADENOMA, SOMATIC, PARAGANGLIOMAS 2, CARDIOFACIOCUTANEOUS SYNDROME, NEUTROPENIA, SEVERE CONGENITAL 1, AUTOSOMAL DOMINANT, IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION AND NEOPLASIA, RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER, ?RAS-ASSOCIATED AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME TYPE IV, SOMATIC, FANCONI ANEMIA, COMPLEMENTATION GROUP N, ALVEOLAR SOFT-PART SARCOMA, HYSTRIX-LIKE ICHTHYOSIS WITH DEAFNESS, AGAMMAGLOBULINEMIA, X-LINKED 1, {NEUROBLASTOMA, SUSCEPTIBILITY TO, 1}, NEUROBLASTOMA, TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1, RUBINSTEIN-TAYBI SYNDROME, DIAPHANOSPONDYLODYSOSTOSIS, SMITH-LEMLI-OPITZ SYNDROME, ONCOCYTOMA, OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS, OVARIAN CARCINOMA, SOMATIC,; OVARIAN CANCER, SOMATIC,; ADENOCARCINOMA, OVARIAN, SOMATIC,; {OVARIAN CANCER, SOMATIC},; OVARIAN CARCINOMA, BIRT-HOGG-DUBE SYNDROME, {HEMANGIOMA, CAPILLARY INFANTILE, SUSCEPTIBILITY TO}, HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC, COWDEN SYNDROME 2, DESMOSTEROLOSIS, {COLORECTAL CANCER, SUSCEPTIBILITY TO, 10}, {HODGKIN LYMPHOMA, SUSCEPTIBILITY TO}, MISMATCH REPAIR CANCER SYNDROME, ?IMMUNODEFICIENCY 16, {HYPOTHALAMIC HAMARTOMAS, SOMATIC}, 46XY SEX REVERSAL 7, {RHABDOID TUMOR PREDISPOSITION SYNDROME 2}, PITUITARY DEPENDENT HYPERCORTISOLISM, POLYPOSIS SYNDROME, HEREDITARY MIXED, 2, CATSHL SYNDROME, SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2, KERATOSIS, SEBORRHEIC, SOMATIC, CITRULLINEMIA, ADULT-ONSET TYPE II, LYNCH SYNDROME I, {BUDD-CHIARI SYNDROME}, MYXOID LIPOSARCOMA, AICARDI-GOUTIERES SYNDROME 1, DOMINANT AND RECESSIVE, BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA, TUBEROUS SCLEROSIS 2, MULTIPLE ENDOCRINE NEOPLASIA 1, GALACTOSIALIDOSIS, XERODERMA PIGMENTOSUM, GROUP E, DDB-NEGATIVE SUBTYPE, {KAPOSI SARCOMA, SUSCEPTIBILITY TO}, UV-SENSITIVE SYNDROME 1, SCHOPF-SCHULZ-PASSARGE SYNDROME, RETINOBLASTOMA, TRILATERAL, RETINOBLASTOMA, PACHYONYCHIA CONGENITA 2, FUMARASE DEFICIENCY, CARNEY COMPLEX VARIANT, CORNELIA DE LANGE SYNDROME 4, WHIM SYNDROME, LI-FRAUMENI SYNDROME, {MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO},; MYELODYSPLASTIC SYNDROME, SOMATIC, CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2, GLIOMA SUSCEPTIBILITY 1, COFFIN-SIRIS SYNDROME 1, CHONDROSARCOMA, LYMPHOPROLIFERATIVE SYNDROME 1, {MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO}, NEUROFIBROMATOSIS, TYPE 2, T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC MALFORMATIONS, HEPATOCELLULAR CANCER, SOMATIC, HEPATOCELLULAR CARCINOMA, HEPATOBLASTOMA, SOMATIC, HEPATOCELLULAR CARCINOMA, SOMATIC, HEPATOCELLULAR CARCINOMA, CHILDHOOD TYPE, SOMATIC, THYROID DYSHORMONOGENESIS 3, PERLMAN SYNDROME, DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1, {SPITZ NEVUS OR NEVUS SPILUS, SOMATIC}, MELANOCYTIC NEVUS SYNDROME, CONGENITAL, SOMATIC, ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA, MCCUNE-ALBRIGHT SYNDROME, SOMATIC, MOSAIC, CHOROID PLEXUS PAPILLOMA, PARAGANGLIOMAS 1, WITH OR WITHOUT DEAFNESS, INFANTILE MYOFIBROMATOSIS 1, NOONAN SYNDROME 3, MALIGNANT LYMPHOMA, NON-HODGKIN, PANCREATIC CANCER/MELANOMA SYNDROME, ANDROGEN INSENSITIVITY, MENINGIOMA, {MENINGIOMA}, MENINGIOMA, SIS-RELATED, {MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO}, MENINGIOMA, NF2-RELATED, SOMATIC, GLUCOSE-6-PHOSPHATE TRANSPORT DEFECT, LERI-WEILL DYSCHONDROSTEOSIS, UTERINE LEIOMYOMA, LYMPHOPROLIFERATIVE SYNDROME 2, MAST CELL DISEASE, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE, MELANOMA, MALIGNANT, SOMATIC, MALIGNANT MELANOMA, SOMATIC



It has 422 associated genes.

Show genes

Associated genes: UROD, MSH6, TCTN3, TSC2, FUZ, EPCAM, TCF3, IGF2R, GLI3, BMPR1A, RBBP8, SPINK1, FAM175A, KIF7, ESCO2, FH, SEC23A, G6PC, TGFBR2, CREBBP, WWOX, DDB2, NF2, TET2, FGFR3, GPR101, AXIN2, HAMP, AR, FCN3, GNAS, PICALM, SHMT1, THPO, BUB1B, MT-ND6, MGAT2, IFNG, MCC, CBL, SMARCE1, CCND1, DHH, NTHL1, NKX2-1, T, TNNT2, SH2D1A, ACVR1B, GATA1, RMRP, FANCE, CTNNB1, NRAS, SUFU, SMAD4, ETV6, NUP214, TUBB, AKT1, SMARCB1, KAT5, AIP, RARA, BRIP1, RAD54B, ARID1B, KRT17, NR4A3, TWIST1, RECQL4, SLC19A1, IL1B, PPP2R1B, TFE3, IL1RN, XPC, POLA1, HMBS, HABP2, LRP5, PAX7, ITK, MLF1, AURKA, TGM6, CHIC2, PIGL, POU6F2, PTPN11, CXCR4, PTPN12, PIEZO2, DICER1, TBX18, FLT3, WNT10A, TMC8, ABCC11, OGG1, BDNF, ERCC6, CALR, DIRC2, EGFR, DHCR24, KRT6B, TSC1, GNPTAB, TREX1, MYC, SCRIB, F5, CTHRC1, ICR1, SF3B1, WRAP53, ASCC1, MTAP, RNF139, WT1, COL4A5, CDKN3, NBN, TAL1, PRF1, CDC73, ERBB2, EPHB2, GNAI2, SBDS, CBFB, ACAN, MLH3, SLC26A4, TFAP2A, NME1, NOTCH1, IDH2, ERCC3, NPM1, FGFR1, TMC6, RASSF1, PRCC, SPRED1, EDN3, MEN1, GDNF, BAP1, WDPCP, FANCA, STS, RB1, BRAF, EWSR1, PDGFRL, TSG101, FOLR1, SFTPA1, MUTYH, OPCML, RASA1, FLT4, SRP72, MSH3, BMP2, KLHDC8B, SOX2, ASCL1, PARK2, TP53, HLA-DQB1, CELSR1, CASP8, SH3GL1, MN1, VANGL2, NF1, PTPRJ, KCNH1, ANTXR1, POLH, KIT, TLR2, DDIT3, SHOXY, BARD1, SLC26A2, PAX3, ASXL1, SDHA, NTRK1, RNF6, RRAS2, MTR, NQO2, SDHB, MAP3K1, TFR2, MLLT10, PMVK, CYP2A6, TINF2, IL6, PHB, OFD1, APC, RNASEL, ADA, EPOR, MSR1, SDHAF2, ODC1, JAK2, SFTPA2, RAD21, PLAG1, ATRX, SQSTM1, CTSA, AP2S1, ATP6V1B2, SEPT9, MTHFR, FOXI1, CDH1, SOS1, PAX5, STK11, MAP3K8, CDKN1C, MMP1, FANCM, NUMA1, PIK3CA, BMPER, JAG1, SMO, MXRA5, FANCD2, SRD5A3, LIG4, RUNX1, RB1CC1, LZTR1, ABCB11, GATA2, SDHC, WHSC1L1, MET, KARS, SLC25A13, FOXO1, BCR, ASPSCR1, MLH1, BCPR, DEC1, DKC1, CYLD, COL7A1, SSX1, SETBP1, MUC5B, RPS14, DDX41, EXT1, SH2B3, PPM1D, GNA11, KIF1B, BRCA1, FN1, MNX1, POLD1, CDK4, TERT, HNF1A, RPS19, H19, PTEN, TNFRSF10B, LPP, FAH, SERPINC1, KLF6, RHBDF2, TLR4, CYP2D6, DPM1, SSX2, BCL10, TAF15, ATP7A, PDGFRA, ERCC4, MLLT11, NEK1, TMEM127, POLE, DOCK8, BAX, GBA, RET, CREB1, HRAS, GPC6, MYH8, HMGA2, MT-CO1, TRIM37, PALB2, PDGFB, BRCA2, USP8, SMAD7, DIS3L2, CHRNG, CHEK2, MYD88, TYR, STK10, HAX1, PPARG, PRKAR1A, VANGL1, BTK, ING1, CDKN2A, DACT1, HNF1B, SMARCA4, DLC1, SNAI2, PDGFRB, BLM, HLA-DQA1, MITF, PTCH1, SDHD, KRAS, FGFR2, FLCN, WRN, IDH1, TERC, PTCH2, CDKN1B, MPL, CD27, FANCG, FANCC, TGFBR1, EP300, RAD51, CEBPA, MAX, TNFRSF4, NOTCH3, EYA1, ABCA5, TNFRSF13B, IRF1, VHL, RAD54L, TAL2, PNP, MTUS1, TG, SIX1, STK4, EIF2AK4, GNAQ, ELANE, EXT2, SHOX, C5orf42, PHOX2B, MAP2K2, SLX4, GFI1, CCL2, MCM4, SLC37A4, XRCC3, MED12, SERPINA1, AXIN1, HMMR, CSF3R, FLNA, MAGT1, GJB2, DHCR7, CASP10, ATM, ING3, NSD1, ESR1, PLA2G2A, ARHGAP26, ALX3, MSH2, TRIM28, ANTXR2, PMS2, RTEL1, GPC3, KCNQ1OT1, LZTS1, HFE, DLEC1, SPRTN, DCC, FASLG, ATR, KLLN, SLC22A18, KDR, MTRR, HFE2



GO terms for Biological Process
--> -->
 
 
<type 'exceptions.TypeError'>
Python 2.7.9: /usr/bin/python
Tue Jun 9 01:08:30 2020

A problem occurred in a Python script. Here is the sequence of function calls leading up to the error, in the order they occurred.

 /usr/lib/cgi-bin/phenpath/class_page_mkstatic.py in ()
    307         print '<p> This is a cluster of phenotypes following the categories of HPO </p>'
    308         initial_description(cla,HPOid2mim,HPOid2gene)
=>  309         myGO_BP,myGO_MF,myGO_CC=main_program(cla,name,HPOid2gene[cla],HPOid2mim[cla],True)
    310         create_metadata(cla,name,HPOid2gene[cla],HPOid2mim[cla],myGO_BP,myGO_MF,myGO_CC)
    311     elif cla=="HP:0000001":
myGO_BP = set([]), myGO_MF = set([]), myGO_CC = set([]), main_program = <function main_program>, cla = 'HP:0002664', name = 'NEOPLASM', HPOid2gene = {'HP:0000001': set(['A2M', 'A4GALT', 'AAAS', 'AAGAB', 'AARS', 'AARS2', ...]), 'HP:0000002': set(['AAAS', 'AARS', 'AASS', 'ABAT', 'ABCB11', 'ACAN', ...]), 'HP:0000003': set(['AMER1', 'B9D1', 'KAT6B', 'MBTPS2', 'OFD1', 'PAX2', ...]), 'HP:0000005': set(['A2M', 'A4GALT', 'AAAS', 'AAGAB', 'AARS', 'AARS2', ...]), 'HP:0000006': set(['A2M', 'A4GALT', 'AAGAB', 'AARS', 'ABCA1', 'ABCA4', ...]), 'HP:0000007': set(['AAAS', 'AARS', 'AARS2', 'AASS', 'ABAT', 'ABCA1', ...]), 'HP:0000008': set(['AARS2', 'AGPAT2', 'AIP', 'AIRE', 'AKT1', 'APC', ...]), 'HP:0000009': set(['ABCD1', 'ACTG2', 'ADH1C', 'AFF4', 'ALDH18A1', 'ALS2', ...]), 'HP:0000010': set(['BTK', 'CFI', 'CIITA', 'CLDN16', 'CLDN19', 'FLVCR1', ...]), 'HP:0000011': set(['ARNT2', 'GBE1', 'GJA1', 'MNX1', 'VANGL1', 'WFS1']), ...}, HPOid2mim = {'HP:0000001': set(['100070', '100100', '100300', '100800', '101000', '101200', ...]), 'HP:0000002': set(['100800', '101400', '101800', '102370', '102500', '103580', ...]), 'HP:0000003': set(['107480', '120330', '143400', '300209', '300373', '308205', ...]), 'HP:0000005': set(['100100', '100300', '100800', '101000', '101200', '101400', ...]), 'HP:0000006': set(['100300', '100800', '101000', '101200', '101400', '101600', ...]), 'HP:0000007': set(['100100', '100300', '102530', '102700', '103050', '105400', ...]), 'HP:0000008': set(['101200', '107480', '109400', '110100', '114500', '119500', ...]), 'HP:0000009': set(['105210', '107480', '109150', '113650', '118450', '120330', ...]), 'HP:0000010': set(['176450', '209920', '220100', '236730', '248190', '248250', ...]), 'HP:0000011': set(['164200', '176450', '222300', '263570', '600145', '615926']), ...}, builtin True = True
 /usr/lib/cgi-bin/phenpath/class_page_mkstatic.py in main_program(cla='HP:0002664', name='NEOPLASM', gene_set=set(['ABCA5', 'ABCB11', 'ABCC11', 'ACAN', 'ACVR1B', 'ADA', ...]), mim_set=set(['101000', '101400', '102200', '102700', '105650', '109400', ...]), HPO=True)
    190         else:
    191             myresult=main_table_printer(cla,name,"allclass2BP_NETGE",gene_set,"GOBP",mim_set,gene2mim_mapped,gene2chrom,root_GOBP_set)
=>  192             summary_shared_other_pages("GO terms for Biological Process",myresult,cla,"GOBP",name)
    193             myresult=main_table_printer(cla,name,"allclass2MF_NETGE",gene_set,"GOMF",mim_set,gene2mim_mapped,gene2chrom,root_GOMF_set)
    194             summary_shared_other_pages("GO terms for Molecular Function",myresult,cla,"GOMF",name)
global summary_shared_other_pages = <function summary_shared_other_pages>, myresult = ('<table id=allclass2BP_NETGE class="display"> <th...e=PDGFB">PDGFB</a></p></td></tr></tbody> </table>', set(['GO:0000018', 'GO:0000075', 'GO:0000077', 'GO:0000079', 'GO:0000082', 'GO:0000122', ...])), cla = 'HP:0002664', name = 'NEOPLASM'
 /usr/lib/cgi-bin/phenpath/class_page_mkstatic.py in summary_shared_other_pages(titlename='GO terms for Biological Process', content=('<table id=allclass2BP_NETGE class="display"> <th...e=PDGFB">PDGFB</a></p></td></tr></tbody> </table>', set(['GO:0000018', 'GO:0000075', 'GO:0000077', 'GO:0000079', 'GO:0000082', 'GO:0000122', ...])), phen='HP:0002664', onto_name='GOBP', cla_name='NEOPLASM')
    110         myfile.write("<h1>"+ " ".join(cla_name.split("_")) +"</h1>")             
    111 
=>  112         myfile.write(content)   
    113         myfile.write('</body><footer><p>Contact information: giulia.babbi3@unibo.it <a style="float:right"> <!-- Release 12-05-2017 --> </a></p></footer></html>')
    114 
myfile = <open file '/var/www/phenpath/class_static/HP:0002664_GOBP_static.html', mode 'w'>, myfile.write = <built-in method write of file object>, content = ('<table id=allclass2BP_NETGE class="display"> <th...e=PDGFB">PDGFB</a></p></td></tr></tbody> </table>', set(['GO:0000018', 'GO:0000075', 'GO:0000077', 'GO:0000079', 'GO:0000082', 'GO:0000122', ...]))

<type 'exceptions.TypeError'>: expected a character buffer object
      args = ('expected a character buffer object',)
      message = 'expected a character buffer object'